By Tony Winterburn • Published: 07 May 2020 • 7:26
EARLY lab tests showed the antibodies created in test mice after they were given the new vaccine were able to halt human cells being infected with Covid-19.
The jab is being developed by Rome-based Takis Biotech, Takis chief executive Luigi Aurisicchio revealed the Italian team plans to start trials in the autumn, as scientists race to halt the pandemic.
He said: “As far as we know we are the first in the world so far to have demonstrated a neutralisation of the coronavirus by a vaccine.” Scientists across the world have been clamouring to develop a vaccine against the disease, which has so far killed more than 260,000 people worldwide.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our Privacy Policy for more information about our privacy practices.
Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
i was hoping were the Italians! Well done!
Comments are closed.
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Download our media pack in either English or Spanish.